Stankovic Marko, Zeljkovic Aleksandra, Vekic Jelena, Antonic Tamara, Ardalic Daniela, Miljkovic-Trailovic Milica, Munjas Jelena, Saric Matutinovic Marija, Gojkovic Tamara, Jovicic Snezana, Mikovic Zeljko, Stefanovic Aleksandra
Gynecology and Obstetrics Clinic Narodni Front, 11000 Belgrade, Serbia.
Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
Antioxidants (Basel). 2024 Aug 3;13(8):948. doi: 10.3390/antiox13080948.
This study investigated the longitudinal trajectory of changes in antioxidative and anti-inflammatory high-density lipoprotein (HDL) components during healthy pregnancy and pregnancy with cardiometabolic complications. We recruited and longitudinally followed 84 women with healthy pregnancies and 46 pregnant women who developed cardiometabolic pregnancy complications (gestational diabetes mellitus and hypertensive disorders of pregnancy). Their general lipid profiles, oxidative stress status, inflammatory status, and antioxidative and anti-inflammatory HDL components were analyzed. The results of our study confirmed the expected trajectory for the routine lipid parameters. Our study results indicate more intensive oxidative stress and a higher level of inflammation in the group with complications compared with the control group. Sphingosine-1-phosphate (S1P) was significantly lower in the first trimester in the group with complications compared with the control group ( < 0.05). We did not find significant differences in the apolipoprotein A1 (Apo A1) concentrations in the first trimester between the control group and the group with complications, but in the second and third trimesters, the group with complications had significantly higher concentrations ( < 0.001, < 0.05, respectively). The S1P, paraoxonase 1 (PON1), and serum amyloid A (SAA) concentrations were significantly lower in the group with complications in the first trimester. During the second trimester, only the SAA concentrations were identified as significantly lower in the group with complications compared with the control group, while in the third trimester, the PON1, apolipoprotein M (Apo M), and SAA concentrations were all significantly lower in the group with complications. Through a multivariate binary logistic regression analysis, the S1P concentration in the first trimester was distinguished as an HDL-associated marker independently associated with cardiometabolic pregnancy complications. In conclusion, our study results showed that HDL remodeling differs between healthy pregnancies and pregnancies with maternal cardiometabolic complications, with changed HDL composition and functionality consequently impacting its biological functionality in the latter case.
本研究调查了健康妊娠以及合并心脏代谢并发症的妊娠过程中抗氧化和抗炎高密度脂蛋白(HDL)成分的纵向变化轨迹。我们招募了84例健康妊娠女性和46例发生心脏代谢妊娠并发症(妊娠期糖尿病和妊娠高血压疾病)的孕妇,并对她们进行纵向随访。分析了她们的一般血脂谱、氧化应激状态、炎症状态以及抗氧化和抗炎HDL成分。我们的研究结果证实了常规血脂参数的预期变化轨迹。我们的研究结果表明,与对照组相比,并发症组的氧化应激更强烈,炎症水平更高。与对照组相比,并发症组在孕早期鞘氨醇-1-磷酸(S1P)显著降低(<0.05)。对照组和并发症组在孕早期载脂蛋白A1(Apo A1)浓度没有显著差异,但在孕中期和孕晚期,并发症组的浓度显著更高(分别为<0.001,<0.05)。并发症组在孕早期S1P、对氧磷酶1(PON1)和血清淀粉样蛋白A(SAA)浓度显著更低。在孕中期,与对照组相比,仅并发症组的SAA浓度被确定为显著更低,而在孕晚期,并发症组的PON1、载脂蛋白M(Apo M)和SAA浓度均显著更低。通过多变量二元逻辑回归分析,孕早期的S1P浓度被确定为与心脏代谢妊娠并发症独立相关的HDL相关标志物。总之,我们的研究结果表明,健康妊娠和合并母体心脏代谢并发症的妊娠之间HDL重塑不同,HDL组成和功能的改变因此在后一种情况下影响其生物学功能。